Hepatocellular Carcinoma Treatment With Sorafenib: Real-Life Evaluation of Prognostic Factors and a Practical Clue for Patient Management

INTRODUCTION: Sorafenib chemotherapy is the first-line therapy for patients with hepatocellular carcinoma (HCC) in an advanced stage. The aim of this study was to evaluate prognostic factors of survival in HCC patients treated with sorafenib, in real-life clinical practice. MATERIAL AND METHODS: Ret...

Descripción completa

Detalles Bibliográficos
Autores principales: Cardoso, Helder, Alves, Ana Margarida, Marques, Margarida, Vale, Ana Maria, Pereira, Pedro, Macedo, Guilherme
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Karger Publishers 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5580019/
https://www.ncbi.nlm.nih.gov/pubmed/28868469
http://dx.doi.org/10.1016/j.jpge.2016.04.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5580019/
https://www.ncbi.nlm.nih.gov/pubmed/28868469
http://dx.doi.org/10.1016/j.jpge.2016.04.006

Ejemplares similares